CLINICAL_TRIALS
trial_result
· 2021-08-20
Clinical Trial Update: Memantine for Refractory OCD Patients [Phase 3]
Summary
Phase 3 clinical trial investigating memantine for refractory obsessive-compulsive disorder is reported as ongoing with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Roma La Sapienza | Conditions: Obsessive-Compulsive Disorder | Phase 3 | Status: UNKNOWN